|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
1.000
|
|
|
|
pancreatic a cell differentiation
|
GO:0003310 |
1 |
1.000
|
|
|
|
enteroendocrine cell differentiation
|
GO:0035883 |
6 |
0.998
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
11 |
0.996
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
6 |
0.988
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.987
|
|
|
|
pancreas development
|
GO:0031016 |
19 |
0.929
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.895
|
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.879
|
|
|
|
positive regulation of monocyte chemotactic protein 1 production
|
GO:0071639 |
3 |
0.857
|
|
|
|
nitric oxide mediated signal transduction
|
GO:0007263 |
7 |
0.829
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.808
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.782
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
1 |
0.761
|
|
|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.715
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
1 |
0.711
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.684
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.668
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.668
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.664
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.658
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.649
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.641
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.615
|
|
|
|
glucose homeostasis
|
GO:0042593 |
31 |
0.609
|
|
|
|
type b pancreatic cell differentiation
|
GO:0003309 |
5 |
0.593
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.593
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014067 |
4 |
0.576
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.566
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.552
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
3 |
0.549
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.547
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.531
|
|
|
|
response to hexose
|
GO:0009746 |
20 |
0.520
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.508
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.501
|
|
|
|
epithelial cell fate commitment
|
GO:0072148 |
3 |
0.494
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.473
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.469
|
|
|
|
blood vessel maturation
|
GO:0001955 |
1 |
0.463
|
|
|
|
aortic valve development
|
GO:0003176 |
3 |
0.462
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
14 |
0.460
|
Fly |
|
|
cardiac chamber formation
|
GO:0003207 |
2 |
0.446
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.436
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.419
|
|
|
|
basophil differentiation
|
GO:0030221 |
2 |
0.419
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.413
|
|
|
|
blastocyst formation
|
GO:0001825 |
3 |
0.412
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.387
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.365
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.362
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.357
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.350
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.349
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.349
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.347
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.345
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.345
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.344
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.342
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.333
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.329
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.327
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.326
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.323
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.316
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.311
|
Fly |
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.304
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.297
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
11 |
0.293
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
31 |
0.289
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.285
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.277
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.276
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.275
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.274
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
25 |
0.273
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
10 |
0.267
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
10 |
0.266
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.266
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.265
|
|
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.264
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
10 |
0.262
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.261
|
Fly |
|
|
response to carbohydrate
|
GO:0009743 |
21 |
0.260
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.256
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.248
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.245
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.243
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
23 |
0.243
|
|
|
|
optic nerve development
|
GO:0021554 |
2 |
0.243
|
|
|
|
negative regulation of histone phosphorylation
|
GO:0033128 |
2 |
0.239
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.232
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.229
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.229
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.225
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.223
|
|
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
22 |
0.223
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.221
|
|
|
|
interleukin 6 production
|
GO:0032635 |
37 |
0.212
|
|
|
|
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
GO:0070059 |
12 |
0.212
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.208
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.208
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.207
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
25 |
0.205
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.205
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.204
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.202
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.199
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.196
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.195
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.191
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.190
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.190
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.189
|
Fly |
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.188
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.182
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.178
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.177
|
|
|
|
bone mineralization
|
GO:0030282 |
34 |
0.174
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
41 |
0.172
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.171
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.167
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.165
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
44 |
0.164
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
11 |
0.163
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.153
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.153
|
|
|
|
positive regulation of lipid catabolic process
|
GO:0050996 |
13 |
0.151
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
65 |
0.151
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.147
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.146
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.144
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.144
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.141
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.141
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.140
|
|
|
|
lipid oxidation
|
GO:0034440 |
33 |
0.139
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.139
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.138
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
38 |
0.137
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.135
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
22 |
0.135
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.134
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.133
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.131
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
10 |
0.129
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.129
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.129
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.128
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.127
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.126
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
29 |
0.124
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
29 |
0.124
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.123
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.121
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
40 |
0.120
|
|
|
|
hair cell differentiation
|
GO:0035315 |
2 |
0.118
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.118
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.117
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.116
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.116
|
Fly |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.114
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
50 |
0.113
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.112
|
|
|
|
chemokine production
|
GO:0032602 |
32 |
0.110
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.110
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.107
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.107
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.107
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.106
|
|
|
|
eyelid development in camera type eye
|
GO:0061029 |
2 |
0.105
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
38 |
0.102
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.102
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.101
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
11 |
0.101
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.101
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
31 |
0.101
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.100
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.098
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.098
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.098
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.098
|
|
|
|
insulin secretion
|
GO:0030073 |
39 |
0.096
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.095
|
|
|
|
cell fate commitment
|
GO:0045165 |
27 |
0.092
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
59 |
0.092
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.092
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
57 |
0.091
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
18 |
0.091
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
37 |
0.090
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
29 |
0.090
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.090
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
23 |
0.089
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
21 |
0.088
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.088
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
11 |
0.088
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.087
|
|
|
|
positive regulation of chromatin assembly or disassembly
|
GO:0045799 |
2 |
0.086
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.086
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.086
|
|
|
|
regulation of insulin secretion
|
GO:0050796 |
33 |
0.084
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
62 |
0.084
|
|
|
|
regulation of transcription regulatory region dna binding
|
GO:2000677 |
15 |
0.083
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
42 |
0.083
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.083
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
14 |
0.082
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.080
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.080
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.079
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.079
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.078
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.077
|
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.077
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.076
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.076
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
60 |
0.075
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.074
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
21 |
0.074
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.074
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.073
|
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
15 |
0.073
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.073
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.073
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.073
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.073
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
48 |
0.072
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.072
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.071
|
|
|
|
biomineral tissue development
|
GO:0031214 |
39 |
0.070
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.069
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
6 |
0.069
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.069
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.069
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
44 |
0.069
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
1 |
0.069
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.069
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.069
|
|
|
|
system process
|
GO:0003008 |
349 |
0.068
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.067
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
15 |
0.066
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.066
|
|
|
|
head development
|
GO:0060322 |
108 |
0.065
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.065
|
|
|
|
positive regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0035774 |
3 |
0.064
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.064
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.064
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.064
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.063
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.062
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.062
|
|
|
|
cellular senescence
|
GO:0090398 |
34 |
0.061
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.060
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.060
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.059
|
|
|
|
glucose metabolic process
|
GO:0006006 |
45 |
0.059
|
|
|
|
regulation of double strand break repair
|
GO:2000779 |
22 |
0.059
|
|
|
|
regulation of dna repair
|
GO:0006282 |
47 |
0.058
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
55 |
0.058
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
19 |
0.057
|
|
|
|
regulation of signal transduction by p53 class mediator
|
GO:1901796 |
26 |
0.057
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.057
|
|
|
|
response to glucose
|
GO:0009749 |
19 |
0.057
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.056
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.056
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
35 |
0.055
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.055
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.055
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.055
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.054
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
8 |
0.054
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.054
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.054
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.054
|
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.053
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
40 |
0.053
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.053
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
43 |
0.052
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.051
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.051
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.051
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
19 |
0.051
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
43 |
0.050
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.050
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.050
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.050
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.050
|
|
|
|
jak stat cascade
|
GO:0007259 |
46 |
0.049
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.049
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.048
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
48 |
0.048
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.047
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.047
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
24 |
0.047
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.047
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.047
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.046
|
|
|
|
digestion
|
GO:0007586 |
22 |
0.046
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.046
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.046
|
|
|
|
signal transduction involved in regulation of gene expression
|
GO:0023019 |
1 |
0.045
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.045
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.045
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.045
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.044
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.044
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.044
|
Worm |
|
|
positive regulation of dna binding
|
GO:0043388 |
17 |
0.044
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
21 |
0.044
|
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.043
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.043
|
|
|
|
positive regulation of transcription regulatory region dna binding
|
GO:2000679 |
8 |
0.043
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
42 |
0.043
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.043
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
16 |
0.041
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.041
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
13 |
0.041
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.040
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
24 |
0.040
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.040
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.040
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.040
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.040
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.039
|
|
|
|
negative regulation of jak stat cascade
|
GO:0046426 |
4 |
0.039
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.039
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.038
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.038
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.037
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.037
|
|
|
|
positive regulation of chemokine production
|
GO:0032722 |
22 |
0.036
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.035
|
|
|
|
inner ear development
|
GO:0048839 |
8 |
0.035
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.035
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
21 |
0.034
|
|
|
|
globus pallidus development
|
GO:0021759 |
1 |
0.034
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.034
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.034
|
|
|
|
positive regulation of interleukin 6 secretion
|
GO:2000778 |
6 |
0.034
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.033
|
|
|
|
monocyte chemotactic protein 1 production
|
GO:0071605 |
6 |
0.033
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
33 |
0.033
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.033
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.033
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.033
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
31 |
0.033
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.032
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
31 |
0.032
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
1 |
0.032
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.032
|
Fly |
|
|
cell projection organization
|
GO:0030030 |
252 |
0.031
|
|
|
|
ear development
|
GO:0043583 |
14 |
0.031
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.031
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.031
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.031
|
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.031
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.030
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.029
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.029
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.029
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
3 |
0.029
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.029
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.028
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.028
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
15 |
0.028
|
|
|
|
telencephalon development
|
GO:0021537 |
17 |
0.028
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.028
|
|
|
|
regulation of cellular senescence
|
GO:2000772 |
13 |
0.027
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.027
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.027
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.027
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.027
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.027
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.026
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.026
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.026
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.026
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.026
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.026
|
|
|
|
menstrual cycle phase
|
GO:0022601 |
2 |
0.025
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.025
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.025
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.025
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.025
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
10 |
0.025
|
|
|
|
specification of symmetry
|
GO:0009799 |
16 |
0.025
|
|
|
|
determination of liver left right asymmetry
|
GO:0071910 |
6 |
0.025
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.025
|
|
|
|
type b pancreatic cell development
|
GO:0003323 |
4 |
0.025
|
|
|
|
heart valve development
|
GO:0003170 |
8 |
0.024
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.024
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.024
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.024
|
|
|
|
axon development
|
GO:0061564 |
34 |
0.024
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
9 |
0.024
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.023
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.023
|
|
|
|
growth
|
GO:0040007 |
202 |
0.023
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.023
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.023
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.023
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.023
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.022
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.022
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.022
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
4 |
0.022
|
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.022
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.022
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
37 |
0.022
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.021
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.021
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
1 |
0.021
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
aging
|
GO:0007568 |
66 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.020
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.020
|
Fly |
|
|
central nervous system development
|
GO:0007417 |
123 |
0.020
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.020
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.020
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.020
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.020
|
Worm |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.019
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
41 |
0.019
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.019
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.019
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.019
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.019
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.019
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.019
|
|
|
|
developmental maturation
|
GO:0021700 |
28 |
0.019
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.019
|
|
|
|
regulation of dna damage response signal transduction by p53 class mediator
|
GO:0043516 |
20 |
0.019
|
|
|
|
outflow tract septum morphogenesis
|
GO:0003148 |
4 |
0.019
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.019
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
21 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.018
|
|
|
|
histone phosphorylation
|
GO:0016572 |
16 |
0.018
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.018
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
22 |
0.018
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.018
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.018
|
|
|
|
cardiac left ventricle morphogenesis
|
GO:0003214 |
6 |
0.018
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.018
|
|
|
|
heart field specification
|
GO:0003128 |
2 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.018
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.018
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.018
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.018
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.018
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.018
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.018
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.017
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.017
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.017
|
|
|
|
right ventricular cardiac muscle tissue morphogenesis
|
GO:0003221 |
2 |
0.017
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.017
|
|
|
|
regulation of chromatin assembly or disassembly
|
GO:0001672 |
6 |
0.017
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.017
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.017
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.017
|
|
|
|
neural retina development
|
GO:0003407 |
8 |
0.017
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.017
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
9 |
0.017
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.017
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.017
|
|
|
|
glandular epithelial cell development
|
GO:0002068 |
5 |
0.017
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.017
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.017
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.016
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.016
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.016
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.016
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.016
|
|